Skip to main content
. Author manuscript; available in PMC: 2023 Aug 1.
Published in final edited form as: J Thorac Cardiovasc Surg. 2021 Dec 23;164(2):389–397.e7. doi: 10.1016/j.jtcvs.2021.12.030

Table 5.

Multivariable analysis of primary and secondary outcomesa

Respiratory complication In-hospital complication Major complication
Characteristic OR 95% CI P value OR 95% CI P value OR 95% CI P value
DLCO change
 Both normal
 Pre- only 1.53 1.05-2.26 0.030 1.12 0.83-1.52 0.5 1.00 0.59-1.71 >0.9
 Impaired-normal 3.19 1.07-8.57 0.027 2.09 0.79-5.44 0.13 1.93 0.29-7.45 0.4
 Both impaired 1.39 0.39-3.90 0.6 0.90 0.33-2.20 0.8 1.86 0.41-6.16 0.4
 Normal-impaired 2.23 1.12-4.29 0.019 2.83 1.55-5.26 <0.001 1.42 0.54-3.33 0.4
Treatment group
 Full
 Abbreviated 1.08 0.73-1.59 0.7 1.23 0.88-1.70 0.2 1.09 0.64-1.83 0.7
 ICI 1.81 0.80-3.83 0.13 1.22 0.60-2.44 0.6 1.40 0.45-3.67 0.5
 Unknown 1.15 0.66-1.94 0.6 1.09 0.70-1.69 0.7 0.65 0.25-1.44 0.3
Procedure type
 Lobectomy/bilobectomy
 Pneumonectomy 0.63 0.33-1.12 0.14 1.30 0.84-1.99 0.2 1.91 1.01-3.42 0.036
 Sublobar 0.56 0.24-1.14 0.14 0.35 0.17-0.65 0.002 0.15 0.01-0.73 0.066
Sex
 Female
 Male 1.68 1.19-2.38 0.003 1.43 1.08-1.89 0.012 1.75 1.08-2.87 0.024
Approach type
 VATS
 Open 1.85 1.20-2.89 0.006
Surgery year 1.05 1.01-1.08 0.004

CI, confidence interval; DLCO, diffusing capacity of the lung for carbon monoxide; ICI, immune checkpoint inhibitor; N/A, not applicable; OR, odds ratio; VATS, video-assisted thoracoscopic surgery.

a

A full univariable analysis is presented in Supplementary Table 10.